0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Contribution |  May 01, 2013
Sleep Quality and Preclinical Alzheimer Disease
Yo-El S. Ju, MD; Jennifer S. McLeland, MSW, MA; Cristina D. Toedebusch, BS; et al.
JAMA Neurol. 2013;70(5):587-593. doi:10.1001/jamaneurol.2013.2334.
INCLUDES: CME , Supplemental Content
Editorial |  May 01, 2013
Can Mild Cognitive Impairment in Parkinson Disease Predict the Development of Dementia?
Brian J. Copeland, MD; Mya C. Schiess, MD
JAMA Neurol. 2013;70(5):553-555. doi:10.1001/jamaneurol.2013.260.
Viewpoint |  April 29, 2013 ONLINE FIRST
DNA Aβ42 Vaccination as Possible Alternative Immunotherapy for Alzheimer Disease
Roger N. Rosenberg, MD; Doris Lambracht-Washington, PhD
JAMA Neurol. 2013;():1-2. doi:10.1001/jamaneurol.2013.1502.
Observation |  April 22, 2013 ONLINE FIRST
Progranulin Mutations as Risk Factors for Alzheimer Disease
David C. Perry, MD; Manja Lehmann, PhD; Jennifer S. Yokoyama, PhD; et al.
JAMA Neurol. 2013;():1-5. doi:10.1001/2013.jamaneurol.393.
Original Contribution |  April 15, 2013 ONLINE FIRST
C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease
Matthew Harms, MD; Bruno A. Benitez, MD; Nigel Cairns, PhD; et al.
JAMA Neurol. 2013;():1-6. doi:10.1001/2013.jamaneurol.537.
INCLUDES: , Supplemental Content
Original Contribution |  April 15, 2013 ONLINE FIRST
A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies
Michael A. Nalls, PhD; Raquel Duran, PhD; Grisel Lopez, MD; et al.
JAMA Neurol. 2013;():1-9. doi:10.1001/jamaneurol.2013.1925.
INCLUDES: , Supplemental Content
Original Contribution |  April 01, 2013
White Matter Hyperintensities and Cerebral Amyloidosis:  Necessary and Sufficient for Clinical Expression of Alzheimer Disease?
Frank A. Provenzano, MS; Jordan Muraskin, MS; Giuseppe Tosto, MD; et al.
JAMA Neurol. 2013;70(4):455-461. doi:10.1001/jamaneurol.2013.1321.
Editorial |  April 01, 2013
Contribution of Cerebrovascular Health to the Diagnosis of Alzheimer Disease
Karen M. Rodrigue, PhD
JAMA Neurol. 2013;70(4):438-439. doi:10.1001/jamaneurol.2013.1862.
Original Contribution |  April 01, 2013
The Aging Brain and Cognition:  Contribution of Vascular Injury and Aβ to Mild Cognitive Dysfunction
Natalie L. Marchant, PhD; Bruce R. Reed, PhD; Nerses Sanossian, MD; et al.
JAMA Neurol. 2013;70(4):488-495. doi:10.1001/2013.jamaneurol.405.
Clinical Implications of Basic Neuroscience Research |  April 01, 2013
Cerebrovascular Effects of Apolipoprotein E:  Implications for Alzheimer Disease
Berislav V. Zlokovic, MD, PhD
JAMA Neurol. 2013;70(4):440-444. doi:10.1001/jamaneurol.2013.2152.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
News From the Centers for Disease Control and Prevention  |  May 01, 2013
Alzheimer Deaths Increased During the Previous Decade
JAMA
Editorial  |  April 10, 2013
Genome-Wide Association Studies, Alzheimer Disease, and Understudied Populations
Robert L. Nussbaum, MD
JAMA
Original Contribution  |  April 10, 2013
Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ϵ4,and the Risk of Late-Onset Alzheimer Disease in African Americans
Christiane Reitz, MD, PhD; Gyungah Jun, PhD; Adam Naj, PhD; et al.
JAMA Internal Medicine
Viewpoint  |  April 8, 2013
The Complexity of Integrating Speed and Safety in Drug Development and Approval
R. Alta Charo, JD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems